They have the cash for about anything. At sub 30, I would suggest authorizing a sizable buy-back. I know that it is rare in bio-land and somewhat risky given the "cure" nature of its drugs, but where can it find a similar return?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.